Found: 153
Select item for more details and to access through your institution.
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 11, p. 3115, doi. 10.1093/rheumatology/keae060
- By:
- Publication type:
- Article
Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 4, p. 227, doi. 10.1002/acr2.11537
- By:
- Publication type:
- Article
World Arthritis Day 2018 ‐ Perspectives on Rheumatic musculoskeletal diseases.
- Published in:
- European Journal of Immunology, 2018, v. 48, n. 10, p. 1604, doi. 10.1002/eji.201870125
- By:
- Publication type:
- Article
Model answers: Rational application of murine models in arthritis research.
- Published in:
- European Journal of Immunology, 2018, v. 48, n. 1, p. 32, doi. 10.1002/eji.201746938
- By:
- Publication type:
- Article
IL-33 induces skin inflammation with mast cell and neutrophil activation.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 8, p. 2229, doi. 10.1002/eji.201041360
- By:
- Publication type:
- Article
Inflammation Is Present in Early Human Tendinopathy.
- Published in:
- American Journal of Sports Medicine, 2010, v. 38, n. 10, p. 2085, doi. 10.1177/0363546510372613
- By:
- Publication type:
- Article
Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1610-3
- By:
- Publication type:
- Article
Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3).
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, p. 1, doi. 10.1186/s13075-018-1551-x
- By:
- Publication type:
- Article
A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1128-5
- By:
- Publication type:
- Article
Evidence that cytokines play a role in rheumatoid arthritis.
- Published in:
- Journal of Clinical Investigation, 2008, v. 118, n. 11, p. 3537, doi. 10.1172/JCI36389
- By:
- Publication type:
- Article
Gait rehabilitation for foot and ankle impairments in early rheumatoid arthritis: a feasibility study of a new gait rehabilitation programme (GREAT Strides).
- Published in:
- Pilot & Feasibility Studies, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40814-022-01061-9
- By:
- Publication type:
- Article
Changes in Plasma Itaconate Elevation in Early Rheumatoid Arthritis Patients Elucidates Disease Activity Associated Macrophage Activation.
- Published in:
- Metabolites (2218-1989), 2020, v. 10, n. 6, p. 241, doi. 10.3390/metabo10060241
- By:
- Publication type:
- Article
Vancomycin Wrap for Anterior Cruciate Ligament Surgery: Molecular Insights.
- Published in:
- American Journal of Sports Medicine, 2021, v. 49, n. 2, p. 426, doi. 10.1177/0363546520981570
- By:
- Publication type:
- Article
Looking through the 'window of opportunity': is there a new paradigm of podiatry care on the horizon in early rheumatoid arthritis?
- Published in:
- Journal of Foot & Ankle Research, 2010, v. 3, p. 8, doi. 10.1186/1757-1146-3-8
- By:
- Publication type:
- Article
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy.
- Published in:
- Nature Medicine, 2013, v. 19, n. 7, p. 822, doi. 10.1038/nm.3260
- By:
- Publication type:
- Article
Primed for inflammation: enthesis-resident T cells.
- Published in:
- Nature Medicine, 2012, v. 18, n. 7, p. 1018, doi. 10.1038/nm.2854
- By:
- Publication type:
- Article
Optimization of current and future therapy for autoimmune diseases.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
A fork in the pathway to inflammation and arthritis.
- Published in:
- Nature Medicine, 2005, v. 11, n. 6, p. 601, doi. 10.1038/nm0605-601
- By:
- Publication type:
- Article
IL-17A mediates inflammatory and tissue remodelling events in early human tendinopathy.
- Published in:
- Scientific Reports, 2016, p. 27149, doi. 10.1038/srep27149
- By:
- Publication type:
- Article
Sphingosine-1-Phosphate Promotes the Persistence of Activated CD4 T Cells in Inflamed Sites.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01627
- By:
- Publication type:
- Article
Identification of Urinary Peptide Biomarkers Associated with Rheumatoid Arthritis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104625
- By:
- Publication type:
- Article
MiR-155 Has a Protective Role in the Development of Non-Alcoholic Hepatosteatosis in Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072324
- By:
- Publication type:
- Article
Th17 Effector Cells Support B Cell Responses Outside of Germinal Centres.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049715
- By:
- Publication type:
- Article
Soluble ST2 Associates with Diabetes but Not Established Cardiovascular Risk Factors: A New Inflammatory Pathway of Relevance to Diabetes?
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047830
- By:
- Publication type:
- Article
Impact of the COVID‐19 pandemic on recruitment to clinical research studies in rheumatology.
- Published in:
- Musculoskeletal Care, 2022, v. 20, n. 1, p. 209, doi. 10.1002/msc.1561
- By:
- Publication type:
- Article
Patient and researcher perspectives on facilitating patient and public involvement in rheumatology research.
- Published in:
- Musculoskeletal Care, 2017, v. 15, n. 4, p. 395, doi. 10.1002/msc.1171
- By:
- Publication type:
- Article
Psoriatic arthritis: tissue-directed inflammation?
- Published in:
- Clinical Rheumatology, 2018, v. 37, n. 4, p. 859, doi. 10.1007/s10067-018-4012-7
- By:
- Publication type:
- Article
Disease-associated functions of IL-33: the new kid in the IL-1 family.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Cytokines in the pathogenesis of rheumatoid arthritis.
- Published in:
- Nature Reviews Immunology, 2007, v. 7, n. 6, p. 429, doi. 10.1038/nri2094
- By:
- Publication type:
- Article
Type-I interferon pathway and DNA damage accumulation in peripheral blood of patients with psoriatic arthritis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1274060
- By:
- Publication type:
- Article
Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients With Psoriatic Arthritis: A Pooled Analysis Across Phase III and Long-Term Extension Studies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ustekinumab Treatment and Improvement of Physical Function and Health-Related Quality of Life in Patients With Psoriatic Arthritis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Radiographic Progression of Patients With Psoriatic Arthritis Who Achieve Minimal Disease Activity in Response to Golimumab Therapy: Results Through 5 Years of a Randomized, Placebo-Controlled Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Patient-Reported Outcomes and the Association With Clinical Response in Patients With Active Psoriatic Arthritis Treated With Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Arthritis Care & Research, 2013, v. 65, n. 10, p. 1666, doi. 10.1002/acr.22044
- By:
- Publication type:
- Article
Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis.
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 6, p. 769, doi. 10.3899/jrheum.220928
- By:
- Publication type:
- Article
Does Age Matter in Psoriatic Arthritis? A Narrative Review.
- Published in:
- Journal of Rheumatology, 2022, v. 40, n. 10, p. 1085, doi. 10.3899/jrheum.210349
- By:
- Publication type:
- Article
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Association Between Enthesitis and Health-related Quality of Life in Psoriatic Arthritis in Biologic-naive Patients from 2 Phase III Ustekinumab Trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain.
- Published in:
- FASEB Journal, 2016, v. 30, n. 1, p. 54, doi. 10.1096/fj.14-267146
- By:
- Publication type:
- Article
Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study.
- Published in:
- BMC Rheumatology, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41927-024-00375-w
- By:
- Publication type:
- Article
Differences in transcriptional changes in psoriasis and psoriatic arthritis skin with immunoglobulin gene enrichment in psoriatic arthritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 1, p. 218, doi. 10.1093/rheumatology/kead195
- By:
- Publication type:
- Article
Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis.
- Published in:
- Rheumatology, 2023, v. 62, n. 4, p. 1417, doi. 10.1093/rheumatology/keac500
- By:
- Publication type:
- Article
review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition.
- Published in:
- Rheumatology, 2022, v. 61, n. 5, p. 1783, doi. 10.1093/rheumatology/keab740
- By:
- Publication type:
- Article